At the conclusion of the inspection, the US FDA issued a Form 483, listing 11 observations. Aurobindo Pharma characterised ...

As work progresses on an up-and-coming biologics plant in North Carolina, specialty pharma company Kyowa Kirin has completed ...

Aurobindo Pharma received a Form 483 with 11 observations from the USFDA for its Raleigh plant in North Carolina. The company ...

While the omission of pharmaceuticals from President Donald Trump’s much-anticipated reciprocal tariffs gave the industry a ...

Siddharth Mittal, CEO and Managing Director of Biocon Limited, on Friday questioned who would pay the price to shift their ...

Aurobindo Pharma Ltd on Friday said the US health regulator has issued a Form 483 with 11 observations to the Raleigh plant ...

The inspection was completed on 10 April 2025 and at the conclusion, the USFDA issued a Form 483 with 11 observations. These observations are procedural in nature. Disclaimer: No Business Standard ...

Germany-based Schott Pharma opened an ampoule manufacturing facility in Serbia's central city of Jagodina, it said on Thursday.

Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants ...

Japanese health officials searched a Kobayashi Pharmaceutical Co. plant in Osaka following reports of five deaths linked to its cholesterol-lowering supplements using red yeast. The factory was ...

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

LGM Pharma has announced plans to expand its manufacturing facility in Rosenberg, Texas. The company, which provides tailored ...